Diversify Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,160
Closed -$3.36M 232
2025
Q4
$3.36M Buy
10,160
+427
+4% +$135K 0.11% 145
2025
Q3
$2.88M Sell
9,733
-1,005
-9% -$291K 0.1% 160
2025
Q2
$3.06M Buy
10,738
+4,032
+60% +$1.14M 0.12% 129
2025
Q1
$1.94M Sell
6,706
-614
-8% -$181K 0.12% 125
2024
Q4
$1.92M Sell
7,320
-3,499
-32% -$1.04M 0.11% 140
2024
Q3
$3.46M Sell
10,819
-875
-7% -$286K 0.19% 97
2024
Q2
$3.69M Buy
11,694
+95
+0.8% +$27.9K 0.2% 90
2024
Q1
$3.28M Buy
+11,599
New +$3.39M 0.19% 111

Other funds holding AMGN

Diversify Advisory Services's AMGN Position: Q1 2026 in Review

Diversify Advisory Services sold out of Amgen (AMGN) in Q1 2026, closing a stake of 10,160 shares — an estimated $3.36M sold.

Diversify Advisory Services first reported a position in AMGN in Q1 2024 and held it in 8 quarters. The position peaked at $3.69M in Q2 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Diversify Advisory Services reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Diversify Advisory Services sold 10,160 Amgen shares in Q1 2026, an estimated $3.36M.
  • Diversify Advisory Services first reported a position in Amgen in Q1 2024 and held it in 8 quarters.
  • Diversify Advisory Services's Amgen position peaked at $3.69M in Q2 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Diversify Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.